神经导航引导的经颅组织碎化(NaviTH)系统
研究开发了首个神经导航引导经颅组织碎化(NaviTH)系统及工作流程,并在两具死后96小时内的人尸体和两个离体人颅盖实验中验证。尸体脑内成功创建3个消融灶,初始靶向误差分别为9、3.4和4.4 mm,改进传感器跟踪仪器设计与工作流程后靶向配准误差降至<2 mm,颅骨所致焦点偏移经治疗前像差校正后为0.3 mm,系统总靶向误差为2.5 mm。作者结论为该NaviTH系统在人尸体模型中可行,但精度仍需提高。
要点
- NaviTH系统由360阵元、700 kHz经颅组织碎化阵列、临床神经导航系统及患者-阵列配准和治疗计划软件组成。
- 尸体脑内创建3个消融灶,初始靶向误差在胼胝体、隔区和丘脑靶点分别为9、3.4和4.4 mm。
- 改进传感器跟踪仪器设计与工作流程后靶向配准误差<2 mm,总靶向误差为2.5 mm。
核心结论
- 作者认为,首个NaviTH系统在人尸体模型中的可行性已得到确定;尽管精度仍需提高,该系统有潜力实现无需主动磁共振治疗引导的经颅组织碎化治疗。
研究设计与样本
- 研究为NaviTH系统开发与可行性验证,使用两具死后96小时内的人尸体和两个离体人颅盖进行实验;系统包括360阵元、700 kHz收发兼备的经颅组织碎化阵列、临床神经导航系统及患者-阵列配准与治疗计划靶向软件。
关键影像表现/征象
- 治疗后磁共振成像证实尸体脑内成功创建消融灶,共3个消融灶。
- 胼胝体、隔区和丘脑靶点的靶向误差分别为9、3.4和4.4 mm。
- 误差主要归因于传感器跟踪仪器设计缺陷和治疗工作流程不完善所致的靶向配准误差。
- 治疗前像差校正后,颅骨所致焦点偏移为0.3 mm。
诊断标准与关键数值
- 初始靶向误差:胼胝体9 mm、隔区3.4 mm、丘脑4.4 mm。
- 改进传感器跟踪仪器设计和工作流程后,靶向配准误差<2 mm。
- 治疗前像差校正后颅骨所致焦点偏移0.3 mm。
- 改进后NaviTH系统总靶向误差为2.5 mm。
临床应用与阅片要点
- 作者结论指出NaviTH系统在人尸体模型中可行,但精度仍需提高。
- 作者提出该系统有潜力实现无需主动磁共振治疗引导的经颅组织碎化治疗。
局限性
- 原文结论指出精度仍需提高。
- 研究仅在两具人尸体和两个离体人颅盖中验证,原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The goal of the work described here was to develop the first neuronavigation-guided transcranial histotripsy (NaviTH) system and associated workflow for transcranial ablation.
METHODS: The NaviTH system consists of a 360-element, 700 kHz transmitter-receiver-capable transcranial histotripsy array, a clinical neuronavigation system and associated equipment for patient-to-array co-registration and therapy planning and targeting software systems. A workflow for NaviTH treatments, including pre-treatment aberration correction, was developed. Targeting errors stemming from target registration errors (TREs) during the patient-to-array co-registration process, as well as focal shifts caused by skull-induced aberrations, were investigated and characterized. The NaviTH system was used in treatments of two <96 h post-mortem human cadavers and in experiments in two excised human skullcaps.
RESULTS: The NaviTH was successfully used to create ablations in the cadaver brains as confirmed in post-treatment magnetic resonance imaging A total of three ablations were created in the cadaver brains, and targeting errors of 9, 3.4 and 4.4 mm were observed in corpus callosum, septum and thalamus targets, respectively. Errors were found to be caused primarily by TREs resulting from transducer tracking instrument design flaws and imperfections in the treatment workflow. Transducer tracking instrument design and workflow improvements reduced TREs to <2 mm, and skull-induced focal shifts, following pre-treatment aberration correction, were 0.3 mm. Total targeting errors of the NaviTH system following the noted improvements were 2.5 mm.
CONCLUSIONS: The feasibility of using the first NaviTH system in a human cadaver model has been determined. Although accuracy still needs to be improved, the proposed system has the potential to allow for transcranial histotripsy therapies without requiring active magnetic resonance treatment guidance.
引用
- Choi SW, Komaiha M, Choi D, et al. Neuronavigation-Guided Transcranial Histotripsy (NaviTH) System. Ultrasound Med Biol. 2024. PMID: 38789304. doi:10.1016/j.ultrasmedbio.2024.04.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。